Showing results (71-80 of 136) with videos related to

Sort By:
Pageof 14
Cancer Research|June 4, 2008
Genome-wide copy number analysis in esophageal adenocarcinoma using high-density single-nucleotide polymorphism arraysDerek J Nancarrow, Herlina Y Handoko, B Mark Smithers, et al.
European Journal of Cancer (Oxford, England : 1990)|July 30, 2014
BRAF mutation status is an independent prognostic factor for resected stage IIIB and IIIC melanoma: implications for melanoma staging and adjuvant therapyAndrew P Barbour, Yue Hang Tang, Nicola Armour, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 25, 2025
Sociodemographic Disparities in Melanoma Stage at Diagnosis: The Role of Socioeconomic Status and Residential LocationDanielle Gavanescu, Annette Dobson, Hansa Sharma, et al.
JAMA Dermatology|May 2, 2019
Risk of Melanoma Recurrence After Diagnosis of a High-Risk Primary TumorLena A von Schuckmann, Maria Celia B Hughes, Reza Ghiasvand, et al.
Neurogastroenterology and Motility|December 16, 2025
Disorders of Gut-Brain Interaction (DGBI) Symptoms and Response to Peroral Endoscopic Myotomy in Patients With AchalasiaRonen Ben Jacob, Thomas Fairlie, Nicholas J Talley, et al.
The Journal of Investigative Dermatology|April 7, 2026
Second primary invasive cutaneous melanomas in Queensland over 4 decadesDanny R Youlden, Victoria Atkinson, Mark B Pinkham, et al.
ESMO Open|July 7, 2022
ctDNA as a biomarker of progression in oesophageal adenocarcinomaV F Bonazzi, L G Aoude, S Brosda, et al.
International Journal of Cancer|March 19, 2016
Molecular markers to complement sentinel node status in predicting survival in patients with high-risk locally invasive melanomaCasey J Rowe, Fiona Tang, Maria Celia B Hughes, et al.
Journal of the American Academy of Dermatology|July 17, 2018
Sun protection behavior after diagnosis of high-risk primary melanoma and risk of a subsequent primaryLena A von Schuckmann, Louise F Wilson, Maria Celia B Hughes, et al.
BMC Cancer|July 22, 2015
TOPGEAR: a randomised phase III trial of perioperative ECF chemotherapy versus preoperative chemoradiation plus perioperative ECF chemotherapy for resectable gastric cancer (an international, intergroup trial of the AGITG/TROG/EORTC/NCIC CTG)Trevor Leong, B Mark Smithers, Michael Michael, et al.
Pageof 14